Background: Sarcomas present a unique challenge within healthcare systems due to their rarity and complex treatment requirements. This study explores the economic impact of sarcoma surgeries across three Swiss tertiary healthcare institutions, utilizing a consistent surgical approach by a single surgeon to eliminate variability in surgical expertise as a confounding factor. Methods: By analyzing data from 356 surgeries recorded in a real-world-time data warehouse, this study assesses surgical and hospital costs relative to institutional characteristics and surgical complexity. Results: Our findings reveal significant cost variations driven more by institutional resource management and pricing strategies than by surgical techniques. Surgical and total hospitalization costs were analyzed in relation to tumor dignity and complexity scores, showing that higher complexity and malignancy significantly increase costs. Interestingly, it was found that surgical costs accounted for only one-third of the total hospitalization costs, highlighting the substantial impact of non-surgical factors on the overall cost of care. Conclusions: The study underscores the need for standardized cost assessment practices and highlights the potential of predictive models in enhancing resource allocation and surgical planning. By advocating for value-based healthcare models and standardized treatment guidelines, this research contributes to more equitable and sustainable healthcare delivery for sarcoma patients. These insights affirm the necessity of including a full spectrum of care costs in value-based models to truly optimize healthcare delivery. These insights prompt a reevaluation of current policies and encourage further research across diverse geographical settings to refine cost management strategies in sarcoma treatment.
背景：肉瘤因其罕见性和复杂的治疗需求，在医疗体系中构成了独特的挑战。本研究通过分析瑞士三家三级医疗机构的肉瘤手术数据，探讨其经济影响。为确保手术技术差异不成为混杂因素，所有手术均由同一位外科医生采用统一的手术方法完成。方法：通过分析实时数据仓库记录的356例手术数据，本研究评估了手术及住院费用与机构特征及手术复杂度的关系。结果：研究发现，成本差异主要源于机构资源管理和定价策略，而非手术技术。手术费用和总住院费用与肿瘤性质和复杂度评分相关分析显示，更高的复杂度和恶性程度会显著增加费用。值得注意的是，手术费用仅占总住院费用的三分之一，凸显了非手术因素对整体治疗成本的重大影响。结论：本研究强调需要建立标准化的成本评估体系，并指出预测模型在优化资源分配和手术规划方面的潜力。通过倡导基于价值的医疗模式和标准化治疗指南，本研究有助于为肉瘤患者提供更公平、可持续的医疗服务。这些发现证实，在价值医疗模型中纳入全周期护理成本对于真正优化医疗服务的必要性。研究结果促使对现行政策进行重新评估，并鼓励在不同地域开展进一步研究，以完善肉瘤治疗的成本管理策略。
肿瘤(癌症)患者之家